LIMIQUENT Trademark

Trademark Overview


On Thursday, July 26, 2012, a trademark application was filed for LIMIQUENT with the United States Patent and Trademark Office. The USPTO has given the LIMIQUENT trademark a serial number of 85687219. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 7, 2016. This trademark is owned by Novartis AG. The LIMIQUENT trademark is filed in the Pharmaceutical Products category with the following description:

Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in dermatology; Pharmaceu...
limiquent

General Information


Serial Number85687219
Word MarkLIMIQUENT
Filing DateThursday, July 26, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 7, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 11, 2012

Trademark Statements


Goods and ServicesAnti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in dermatology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, anti-infectives

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 2, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Monday, March 7, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 7, 2016ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 6, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 5, 2015EXTENSION 5 GRANTED
Saturday, August 1, 2015EXTENSION 5 FILED
Saturday, August 1, 2015TEAS EXTENSION RECEIVED
Tuesday, February 24, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 23, 2015EXTENSION 4 GRANTED
Tuesday, February 3, 2015EXTENSION 4 FILED
Tuesday, February 3, 2015TEAS EXTENSION RECEIVED
Tuesday, August 12, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 11, 2014EXTENSION 3 GRANTED
Saturday, August 2, 2014EXTENSION 3 FILED
Saturday, August 2, 2014TEAS EXTENSION RECEIVED
Friday, February 28, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 27, 2014EXTENSION 2 GRANTED
Thursday, January 30, 2014EXTENSION 2 FILED
Monday, February 24, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 30, 2014TEAS EXTENSION RECEIVED
Tuesday, August 6, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 2, 2013EXTENSION 1 GRANTED
Friday, August 2, 2013EXTENSION 1 FILED
Friday, August 2, 2013TEAS EXTENSION RECEIVED
Tuesday, February 5, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 11, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 11, 2012PUBLISHED FOR OPPOSITION
Wednesday, November 21, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 1, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, October 28, 2012ASSIGNED TO EXAMINER
Thursday, August 2, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 30, 2012NEW APPLICATION ENTERED IN TRAM